Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug;9(8):687-694.
doi: 10.14740/jocmr3064w. Epub 2017 Jul 1.

Prevalence of Metabolic Syndrome Among the End-Stage Renal Disease Patients on Hemodialysis

Affiliations

Prevalence of Metabolic Syndrome Among the End-Stage Renal Disease Patients on Hemodialysis

Khaled A Alswat et al. J Clin Med Res. 2017 Aug.

Abstract

Background: Patients with metabolic syndrome (MetS) have a 2.6-fold greater risk of incident chronic kidney disease (CKD). The primary goal of this study was to assess the prevalence of MetS in patients with end-stage renal disease (ESRD) who are on hemodialysis (HD) and the impact of MetS presence on HD-related outcomes.

Methods: This is a cross-sectional study conducted in the Dialysis Center, King Abdulaziz Specialist Hospital, Taif, Saudi Arabia. It was conducted among ESRD patients that attended the Dialysis Center between August 2013 and September 2016. We excluded patients on peritoneal dialysis and those < 18 years old. We used the International Diabetes Federation (IDF) criteria to identify patients with MetS.

Results: A total of 241 patients with ESRD on HD were found, with a mean age of 48.8 (SD 16) years, mean body mass index (BMI) of 25.6 (SD 8.7) kg/m2, and mean waist circumference (WC) of 92.0 (SD 23.5) cm. The mean duration of the HD was 69.3 (SD 65.6) months with arteriovenous fistula (AVF) as the most common access for HD. Of the patients, 38.2% had MetS. Compared to those without MetS, those with MetS were more likely to be older (P < 0.001), be female (P < 0.001), be married (P < 0.001), have higher BMI (P < 0.001), have larger WC (P < 0.001), have T2D and hypertension (HTN) (P < 0.001), have shorter HD duration (P < 0.001), have a longer duration since the AVF was placed (P = 0.026), and have high post-HD creatinine levels (P = 0.010) and were less likely to have adequate HD (P = 0.004) and have parathyroid hormone (PTH) at goal (P = 0.046).

Conclusion: MetS is common among ESRD and MetS was associated with more comorbidity, worse anthropometric measures at baseline, and worse HD-related outcomes. The limitations were small sample size and single center.

Keywords: End-stage renal disease; Metabolic syndrome.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
BMI distribution of the whole cohort.
Figure 2
Figure 2
Causes of the ESRD as percentile.

References

    1. Andrassy KM. Comments on ‘KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease’. Kidney Int. 2013;84(3):622–623. doi: 10.1038/ki.2013.243. - DOI - PubMed
    1. Caskey F, Castledine C, Dawnay A, Farrington K, Fogarty D, Fraser S, Kumwenda M, MacPhee I, Sinha MD, Steenkamp R, Williams AJ. UK Renal Registry. Nephron. 2016. p. 132.
    1. Alberti KG, Zimmet P, Shaw J. Group IDFETFC. The metabolic syndrome—a new worldwide definition. lancet. 2005;366(9491):1059–1062. doi: 10.1016/S0140-6736(05)67402-8. - DOI - PubMed
    1. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004;27(10):2444–2449. doi: 10.2337/diacare.27.10.2444. - DOI - PubMed
    1. Townsend RR, Anderson AH, Chen J, Gadebegku CA, Feldman HI, Fink JC, Go AS. et al. Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Nephrol. 2011;33(6):477–484. doi: 10.1159/000327618. - DOI - PMC - PubMed

LinkOut - more resources